Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

European Journal of Cancer

Volumn 36, Issue 7, 2000, Pages 875-880

  Elomaa, I ^a   Blomqvist, C P ^a   Saeter, G ^b   Akerman M ^c   Stenwig, E ^b   Wiebe, T ^c   Bjork O ^d   Alvegard T A ^c  

^a Univ Hospital Box 180 00029 HYKS ^*  (Finland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ewing's sarcoma; Multimodal therapy; Scandinavian

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CHILD; EWING SARCOMA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOMA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SARCOMA, EWING'S; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0034008816     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00028-9     Document Type: Article

References (45)

1. Alvegård T.A., Solheim O., Åkerman M., Berg N.O. Ewing's sarcoma. A preliminary report from the Scandinavian Sarcoma Group. Acta Oncol. 28(Suppl. 2):1989;59-64.
2. Rosen G., Caparros B., Nirenberg A.et al. Ewing's sarcoma. ten years experience with adjuvant chemotherapy Cancer. 47:1981;2204-2212.
3. Bacci G., Picci P., Cherlinzoni F.et al. Localized Ewing's sarcoma of bone. ten years experience at the Istituto Ortopedico Rizzoli in 124 cases treated with multimodal therapy Eur. J. Cancer Clin. Oncol. 21:1985;165-175.
4. Bacci G., Toni A., Avella M.et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer. 63:1989;1477-1486.
5. Wilkins R.M., Pritchard D.J., Burgert E.O. Jr., Unni K.K. Ewing's sarcoma of bone. Experiences with 140 patients. Cancer. 58:1986;2551-2555.
6. Burgert E.O. Jr., Unni K.K. The role of radiation therapy in the management of nonmetastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's sarcoma study. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;141-145.
7. Jurgens H., Bier V., Dunot D.et al. Die GPO Cooperation Ewing-Sarkom Studien CESS 81/86. Bericht nach 6 1 2 Jahren Klin. Pädiatr. 200:1988;243-252.
8. Dunst J., Saner R., Burgers J.M.V.et al. Radiotherapie beim Ewing-Sarkom. Aktuelle Ergebnisse der GPO-Studien CESS 81 und CESS 86 Klin. Pädiatr. 200:1988;261-266.
9. Jurgens H., Exner U., Gardner H.et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European cooperative trial. Cancer. 61:1988;23-32.
10. Cangir A., Vietti T.J., Gehan E.A.et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer. 66:1990;887-893.
11. Jurgens H., Hoffmann Ch., Kozt R.et al. Multi-disciplinary treatment of Ewing's sarcoma. results of the CESS 81 and 86 studies Eur. J. Cancer. 31A(Suppl. 5):1995;1197.
12. Bone F, Le Chevalier T, Spielman M, et al. Drug chemotherapy of Ewing's sarcoma. ECCO 4, Madrid 1987, A, p. 238.
13. Castello M.A., Dominici C., Clerico A. A pilot study of 5-day continuous infusion of high-dose cisplatin and pulsed etoposide in childhood solid tumors. Am. J. Pediatr. Hematol. Oncol. 10:1988;103-108.
14. Tursz T., Guillot T., Le Chevalier T.et al. A pilot study of common combination chemotherapy (PAVI) for neuroectodermal tumors in young adults. Ewing's sarcoma, malignant neuroepithelioma, Askin's tumor ASCO. 8:1989;A1231.
15. Hayes F.A., Thompson E.I., Meyer W.H.et al. Therapy for localized Ewing's sarcoma of bone. J. Clin. Oncol. 7:1989;208-213.
16. Nesbit M.E.J., Gehan E.A., Burgert E.O.J.et al. Multimodal therapy for management of primary, nonmetastatic Ewing's sarcoma of bone. a long-term follow-up of the first Intergroup study J. Clin. Oncol. 8:1990;1664-1674.
17. Burgert E.O.J., Nesbit M.E., Garnsey L.A.et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone. Intergroup study IESS-II J. Clin. Oncol. 8:1990;1514-1524.
18. Bacci G., Picci P., Avella M.et al. Neoadjuvant chemotherapy for localized Ewing's sarcoma of bone. experience at the Istituto Ortopedico Rizzoli Cancer J. 4:1991;335-342.
19. Gasparini M., Lombardi F., Ballerini E.et al. Long-term outcome in patients with monostatic Ewing's sarcoma treated with combined modality. Med. Ped. Oncol. 23:1994;406-412.
20. Fizazi K., Dohollou N., Spielman M.et al. Adults with Ewing's sarcoma. a retrospective study of 146 cases Eur. J. Cancer. 31A(Suppl. 5):1995;1123.
21. Oberlin O., Bui N.B., Dohollou N.et al. Treatment of localized Ewing's sarcoma in young adults. A study of the French Society of Pediatric Oncology. Eur. J. Cancer. 31A(Suppl. 5):1995;1198.
22. Rosito P., Mancini A.F., Abate M.E.et al. Italian cooperative study for treatment of localized Ewing's sarcoma of bone. Med. Ped. Oncol. 27:1996;0-196.
23. Verrill M.W., Predolac D., Hill C.A.L.et al. Adult Ewing's sarcoma - the Royal Marsden experience. Eur. J. Cancer. 31A(Suppl. 5):1995;1199.
24. Cotterill S.J., Ahrens S., Craft A.W.et al. Prognostic factors in Ewing's tumour - an analysis of 975 patients in the GPOH/CESS and UKCCSG/MRC studies. Med. Ped. Oncol. 27:1996;0-195.
25. Hoffmann Ch, Jabar S, Jurgens H, et al. Pelvic Ewing's sarcoma: a retrospective analysis of 241 patients. Joint Meeting EMSOS-AMSTS, Florence, May 8-9, 1995, A, 13.
26. Burgers J.M.V., Oldenburger J., de Kraker J.et al. Ewing's sarcoma of the pelvis. changes over 25 years in treatment and results Eur. J. Cancer. 33:1997;2360-2367.
27. Horowitz M.E., Kinsella T.J., Wexler L.H.et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J. Clin. Oncol. 11:1993;1911-1918.
28. Burdach S., Jurgens H., Peters C.et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J. Clin. Oncol. 11:1993;1482-1488.
29. Mitchell P.L.R., Shepherd V.B., Proctor H.M.et al. Peripheral blood stem cells used to augment autologous bone marrow transplantation. Arch. Dis. Childhood. 70:1994;237-240.
30. Nooy M.A., Fibbe W., Ouwerkerk J.et al. High-dose chemotherapy (HDC) with stemcell rescue for patients with metastatic Ewing's sarcoma. Eur. J. Cancer. 31A(Suppl. 5):1995;1202.
31. Pape H., Bannach B., Burdach St.et al. Ablative chemotherapy and BMT/PSCT in early relapsing or multifocal Ewing's sarcoma. The value of radiotherapy. Eur. J. Cancer. 31A(Suppl. 5):1995;1123.
32. Valteau-Couanet D., Benhamou E., Oberlin O.et al. Consolidation with busulfan and melphalan followed by hematopoietic stem-cell transplantation (SCT) in children with poor prognosis Ewing's sarcoma. Eur. J. Cancer. 31A(Suppl. 5):1995;1201.
33. Ladenstein R., Peters C., Zoubek A.et al. The role of megatherapy (MGT) followed by stem cell rescue (SCR) in high risk Ewing's tumours (ET). 11 years single center experience. Med. Ped. Oncol. 27A:1996;0-106.
34. Pession A., Tienghi A., Rosito P.et al. Peripheral blood stem cell transplantation (PBSCT) in high risk Ewing's sarcoma. Med. Ped. Oncol. 27A:1996;0-108.
35. Picci P., Rougraff B.T., Bacci G.et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J. Clin. Oncol. 11:1993;1763-1769.
36. Wunder JS, Paulian G, Healey JH, et al. Chemotherapy induced tumour necrosis as a prognostic indicator in surgically treated Ewing's sarcoma. Joint Meeting EMSOS-AMSTS, Florence, May 8-9, 1995, A, 63.
37. Jurgens H, Hoffmann Ch, Braun-Munzinger G, et al. Histological response following preoperative chemotherapy: the CESS experience. Joint Meeting EMSOS-AMSTS, Florence, May 8-9, 1995, A, 63.
38. Saeter G., Elomaa I., Wahlqvist Y.et al. Prognostic factors in bone sarcomas. Acta. Orthop. Scand. 68(Suppl. 273):1997;156-160.
39. Picci P., Böhling T., Bacci G.et al. Chemotherapy induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J. Clin. Oncol. 15:1997;1553-1559.
40. Huvos A. Osteogenic sarcoma. Pathologic assesment of preoperative (neoadjuvant) chemotherapy. In Bone tumours. Diagnosis, treatment and prognosis, 2nd edn. Philadelphia, WB Saunders Co, 1991, 5, 122-128.
41. Åkerman M., Stenwig E. A critical re-examination of Ewing's sarcoma trial SSGIX - primary diagnosis and histologic response grading. Acta. Orthop. Scand. 282(Suppl.):1998;32.
42. Armengol G., Tarkkanen M., Virolainen M.et al. Recurrent gains of 1Q, 8 and 12 in Ewing Family of tumours by comparative genomic hybridization. Br. J. Cancer. 75:1997;403-409.
43. Tarkkanen M., Kiuru-Kuhlefelt S., Blomqvist C.et al. Clinical correlation of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors. Cancer Genet. Cytogenet. 114:1999;35-41.
44. Zoubek A., Dockhorn-Dworniczak B., Delattre O.et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14:1996;1245-1256.
45. de Alva E., Kawai A., Healey J.H.et al. EWS-FLI1 fusion transcript structure in an independent determinant of prognosis in Ewing's sarcoma. J. Clin. Oncol. 16:1998;1248-1255.